Knowledge of quality performance measures associated with endoscopy among gastroenterology trainees and the impact of a web-based intervention.

PubWeight™: 1.59‹?› | Rank: Top 4%

🔗 View Article (PMC 3739290)

Published in Gastrointest Endosc on March 14, 2012

Authors

Jennifer S Thompson1, Benjamin Lebwohl, Sapna Syngal, Fay Kastrinos

Author Affiliations

1: Division of Liver and Digestive Diseases at Columbia University Medical Center, New York, New York 10032, USA.

Articles cited by this

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86

Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med (2010) 11.76

Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med (2006) 10.52

Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology (1997) 7.58

Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol (2002) 6.63

Quality indicators for colonoscopy. Am J Gastroenterol (2006) 6.51

Using the Internet to conduct surveys of health professionals: a valid alternative? Fam Pract (2003) 6.31

Location of adenomas missed by optical colonoscopy. Ann Intern Med (2004) 4.95

Endoscopist can be more powerful than age and male gender in predicting adenoma detection at colonoscopy. Am J Gastroenterol (2007) 4.62

Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology (1997) 4.32

Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin (2006) 3.21

Failure of colonoscopy to detect colorectal cancer: evaluation of 47 cases in 20 hospitals. Gastrointest Endosc (1997) 2.62

Wide variation in adenoma detection rates at screening flexible sigmoidoscopy. Gastroenterology (2004) 2.55

Colonoscopic withdrawal technique is associated with adenoma miss rates. Gastrointest Endosc (2000) 2.26

Prospective study of the frequency and size distribution of polyps missed by colonoscopy. J Natl Cancer Inst (1990) 2.11

Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc (2008) 2.08

Computed tomographic colonography compared with colonoscopy in patients at increased risk for colorectal cancer. Gastroenterology (2004) 1.55

Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc (2002) 1.54

Women's health training in gastroenterology fellowship: a national survey of fellows and program directors. Dig Dis Sci (2011) 1.53

A call to action--measuring the quality of colonoscopy. N Engl J Med (2006) 1.52

Evaluation of polyp detection in relation to procedure time of screening or surveillance colonoscopy. Am J Gastroenterol (2004) 1.40

Excellence in endoscopy: toward practical metrics. Gastrointest Endosc (2006) 1.15

Quality indicators for esophagogastroduodenoscopy. Am J Gastroenterol (2006) 1.06

A journey toward excellence: training future gastroenterologists--the gastroenterology core curriculum, third edition. Am J Gastroenterol (2007) 0.99

Quality and outcomes assessment in gastrointestinal endoscopy. American Society for Gastrointestinal Endoscopy. Gastrointest Endosc (2000) 0.94

AGA Task Force on Quality in Practice: a national overview and implications for GI practice. Gastroenterology (2005) 0.92

"Demand the data! Your patients will ask and your practice will need it". Am J Gastroenterol (2007) 0.87

Colorectal cancer screening perceptions and practices: results from a national survey of gastroenterology, surgery and radiology trainees. J Cancer Educ (2007) 0.79

Articles by these authors

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst (2004) 14.97

ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov (2011) 3.27

Villous atrophy and negative celiac serology: a diagnostic and therapeutic dilemma. Am J Gastroenterol (2013) 3.13

American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers. J Clin Oncol (2014) 3.07

Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA (2004) 2.99

Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population. Cancer Prev Res (Phila) (2010) 2.86

Colonoscopy vs sigmoidoscopy screening: getting it right. JAMA (2010) 2.78

Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology (2009) 2.75

The impact of suboptimal bowel preparation on adenoma miss rates and the factors associated with early repeat colonoscopy. Gastrointest Endosc (2011) 2.73

Prediction of MLH1 and MSH2 mutations in Lynch syndrome. JAMA (2006) 2.73

Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology (2012) 2.69

Decreased risk of celiac disease in patients with Helicobacter pylori colonization. Am J Epidemiol (2013) 2.58

Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families. Cancer Res (2002) 2.33

Risk of pancreatic cancer in families with Lynch syndrome. JAMA (2009) 2.32

Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts. Gut (2012) 2.17

A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor. Cancer Res (2002) 2.07

Pancreatic cancer genetic epidemiology consortium. Cancer Epidemiol Biomarkers Prev (2006) 2.04

Obesity increases the risks of diverticulitis and diverticular bleeding. Gastroenterology (2008) 2.01

Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia. Clin Gastroenterol Hepatol (2012) 1.99

Bibliometric study of the quality of celiac disease research publications. J Pediatr Gastroenterol Nutr (2013) 1.98

Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. Lancet Oncol (2010) 1.98

The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history. Gastroenterology (2010) 1.88

Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients. Clin Gastroenterol Hepatol (2004) 1.76

Colonoscopic screening in average-risk individuals ages 40 to 49 vs 50 to 59 years. Gastroenterology (2008) 1.71

Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk. Genet Med (2011) 1.70

Characteristics of patients who avoid wheat and/or gluten in the absence of Celiac disease. Dig Dis Sci (2013) 1.65

Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps. Cancer Prev Res (Phila) (2012) 1.65

Human urine contains small, 150 to 250 nucleotide-sized, soluble DNA derived from the circulation and may be useful in the detection of colorectal cancer. J Mol Diagn (2004) 1.62

Development and validation of a colon cancer risk assessment tool for patients undergoing colonoscopy. Am J Gastroenterol (2009) 1.62

Risk factors for mortality in lower intestinal bleeding. Clin Gastroenterol Hepatol (2008) 1.55

Survivors of childhood cancer have increased risk of gastrointestinal complications later in life. Gastroenterology (2011) 1.51

Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol (2005) 1.50

Chromoendoscopy detects more adenomas than colonoscopy using intensive inspection without dye spraying. Cancer Prev Res (Phila) (2008) 1.47

Aberrant DNA methylation in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency. Gastroenterology (2010) 1.46

Nut, corn, and popcorn consumption and the incidence of diverticular disease. JAMA (2008) 1.46

The comprehensiveness of family cancer history assessments in primary care. Community Genet (2007) 1.42

Impact of preoperative staging and chemoradiation versus postoperative chemoradiation on outcome in patients with rectal cancer: a decision analysis. J Natl Cancer Inst (2004) 1.42

Hereditary colorectal cancer syndromes. Cancer Causes Control (2005) 1.40

Factors associated with enrollment in cancer genetics research. Cancer Epidemiol Biomarkers Prev (2006) 1.31

Hereditary pancreatic cancer. Gastroenterology (2010) 1.31

Cancer risk assessment: quality and impact of the family history interview. Am J Prev Med (2004) 1.30

Timing of colonoscopy: impact on length of hospital stay in patients with acute lower intestinal bleeding. Am J Gastroenterol (2003) 1.28

Colorectal cancers with microsatellite instability display unique miRNA profiles. Clin Cancer Res (2011) 1.27

F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome. JAMA (2008) 1.26

Sharing genetic test results in Lynch syndrome: communication with close and distant relatives. Clin Gastroenterol Hepatol (2008) 1.20

Early predictors of severity in acute lower intestinal tract bleeding. Arch Intern Med (2003) 1.19

Temporal and geographic trends in celiac disease publications: a bibliometric analysis. Eur J Gastroenterol Hepatol (2012) 1.17

Phenotype comparison of MLH1 and MSH2 mutation carriers in a cohort of 1,914 individuals undergoing clinical genetic testing in the United States. Cancer Epidemiol Biomarkers Prev (2008) 1.16

Validation and extension of the PREMM1,2 model in a population-based cohort of colorectal cancer patients. Gastroenterology (2007) 1.16

Elevated risk of prostate cancer among men with Lynch syndrome. J Clin Oncol (2013) 1.14

Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases. Cancer Res (2009) 1.14

Enhanced retrieval of DNA from human fecal samples results in improved performance of colorectal cancer screening test. J Mol Diagn (2004) 1.11

Missed adenomas during colonoscopic surveillance in individuals with Lynch Syndrome (hereditary nonpolyposis colorectal cancer). Cancer Prev Res (Phila) (2008) 1.11

Determinants of colorectal cancer screening in women undergoing mammography. Am J Gastroenterol (2003) 1.10

Colorectal cancer in young adults. Dig Dis Sci (2014) 1.08

Immunoglobulin A deficiency in celiac disease. J Clin Gastroenterol (2012) 1.08

Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome. Gastroenterology (2006) 1.08

Recurrence and variability of germline EPCAM deletions in Lynch syndrome. Hum Mutat (2011) 1.07

Antibiotic exposure and the development of coeliac disease: a nationwide case-control study. BMC Gastroenterol (2013) 1.07

Inherited colorectal cancer syndromes. Cancer J (2011) 1.06

Gastric cancer in individuals with Li-Fraumeni syndrome. Genet Med (2011) 1.05

Screening for colorectal cancer: the glass is half full. Am J Public Health (2009) 1.05

Validation of a clinical prediction rule for severe acute lower intestinal bleeding. Am J Gastroenterol (2005) 1.04

Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome. Am J Gastroenterol (2010) 1.03

Shortened surveillance intervals following suboptimal bowel preparation for colonoscopy: results of a national survey. Int J Colorectal Dis (2012) 1.02

The impact of family history of diabetes on glucose testing and counseling behavior in primary care. Diabetes Care (2004) 1.02

Genetic testing in gastroenterology: Lynch syndrome. Best Pract Res Clin Gastroenterol (2009) 1.02

Increased incidence of eosinophilic esophagitis in children and adults with celiac disease. J Clin Gastroenterol (2012) 1.01

Impact of socioeconomic status on extent of lymph node dissection for colon cancer. Cancer Epidemiol Biomarkers Prev (2010) 1.00

Comparison of the clinical prediction model PREMM(1,2,6) and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer. Gut (2012) 0.99

Risk of celiac disease according to HLA haplotype and country. N Engl J Med (2014) 0.98

Colon cancer screening strategies. Curr Opin Gastroenterol (2005) 0.98

Predictors of utilization of early colonoscopy vs. radiography for severe lower intestinal bleeding. Gastrointest Endosc (2005) 0.98

Screening for celiac disease in average-risk and high-risk populations. Therap Adv Gastroenterol (2012) 0.97

Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry. JAMA Oncol (2015) 0.96

Colorectal cancer risk perception on the basis of genetic test results in individuals at risk for Lynch syndrome. J Clin Oncol (2009) 0.96

Colorectal cancer screening: prevalence among low-income groups with health insurance. Health Aff (Millwood) (2009) 0.96

Recently identified colon cancer predispositions: MYH and MSH6 mutations. Semin Oncol (2007) 0.94

Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome. Gynecol Oncol (2012) 0.94

Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc (2014) 0.94

Intraductal papillary mucinous neoplasm of the pancreas with loss of mismatch repair in a patient with Lynch syndrome. Am J Surg Pathol (2009) 0.94

Risk assessment, genetic testing, and management of Lynch syndrome. J Natl Compr Canc Netw (2010) 0.92

Screening patients with colorectal cancer for Lynch syndrome: what are we waiting for? J Clin Oncol (2012) 0.92

Interest in medical therapy for celiac disease. Therap Adv Gastroenterol (2013) 0.90

Attitudes toward prenatal genetic testing in patients with familial adenomatous polyposis. Am J Gastroenterol (2007) 0.90

Gastroenterologists' perceived barriers to optimal pre-colonoscopy bowel preparation: results of a national survey. J Cancer Educ (2012) 0.87

Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases. Genet Med (2012) 0.87

Racial and ethnic variations in the effects of family history of colorectal cancer on screening compliance. Gastroenterology (2013) 0.86

Clinical presentation correlates with the type of mismatch repair gene involved in hereditary nonpolyposis colon cancer. Gastroenterology (2004) 0.86

Prevalence of migraine in patients with celiac disease and inflammatory bowel disease. Headache (2012) 0.85

Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Dis Colon Rectum (2014) 0.85

Increased prevalence of celiac disease in patients with unexplained infertility in the United States. J Reprod Med (2011) 0.85

Colorectal cancer screening awareness and intentions among low income, sociodemographically diverse adults under age 50. Cancer Causes Control (2008) 0.85

Celiac disease patients presenting with anemia have more severe disease than those presenting with diarrhea. Clin Gastroenterol Hepatol (2013) 0.85